12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Other News

Altravax, National Institutes of Health infectious news

Altravax received $1.2 million in two equal Advanced Technology Small Business Innovation Research grants from NIH's National Institute of Allergy and Infectious Diseases for...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >